Respectable figures but not mind blowing...23 Sep 2025 12:24
Renalytix plc has released revised forward revenue guidance, anticipating $8.4 million in FY26. The company projects revenue of $19.0 million in FY27 and $42.0 million in FY28, reflecting the expected positive impact from their collaboration with Tempus AI, Inc. This updates the previous outlook provided in the Half Year Report on March 18, 2025, which estimated $8.5 million for FY26 and $17.5 million for FY27. The Board is evaluating the long-term benefits of the Tempus collaboration and plans to provide further updates on revenue guidance as implementation progresses.